Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen Beusterien

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Patient Preference and Adherence|June 11, 2011
Patient preferences in the treatment of diabetic retinopathyBarbara Wirostko, Kathleen Beusterien, Jessica Grinspan, et al.
BMC Research Notes|September 27, 2017
Development of the pediatric daily ulcerative colitis signs and symptoms scale (DUCS): qualitative research findingsEmuella Flood, Debra G Silberg, Beverly Romero, et al.
Current Medical Research and Opinion|December 22, 2005
Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)Ronald Emkey, William Koltun, Kathleen Beusterien, et al.
Journal of Managed Care & Specialty Pharmacy|February 26, 2014
Barriers to mesalamine adherence in patients with inflammatory bowel disease: a qualitative analysisJennifer Devlen, Kathleen Beusterien, Linnette Yen, et al.
Vaccine|September 1, 2024
Preferences for a Clostridioides difficile vaccine among adults in the United StatesJeffrey Vietri, Martine C Maculaitis, Joseph C Cappelleri, et al.
Current Medical Research and Opinion|June 15, 2021
Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experimentTom Tencer, Oliver Will, Jinender Kumar, et al.
Patient Preference and Adherence|March 29, 2021
Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice ExperimentKathleen Beusterien, Martine C Maculaitis, Bernadette Hallissey, et al.
Patient Preference and Adherence|July 16, 2021
Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice ExperimentJinender Kumar, M Janelle Cambron-Mellott, Tom Tencer, et al.
Patient Preference and Adherence|July 31, 2024
Patient Preferences Influencing Treatment Decision-Making in Early-Stage Breast Cancer in Germany, Italy, and JapanEmuella Flood, Susan McCutcheon, Kathleen Beusterien, et al.
Neurourology and Urodynamics|September 16, 2015
Use of best-worst scaling to assess patient perceptions of treatments for refractory overactive bladderKathleen Beusterien, Michael J Kennelly, John F P Bridges, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Patient Preference and Adherence|June 11, 2011
Patient preferences in the treatment of diabetic retinopathyBarbara Wirostko, Kathleen Beusterien, Jessica Grinspan, et al.
BMC Research Notes|September 27, 2017
Development of the pediatric daily ulcerative colitis signs and symptoms scale (DUCS): qualitative research findingsEmuella Flood, Debra G Silberg, Beverly Romero, et al.
Current Medical Research and Opinion|December 22, 2005
Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)Ronald Emkey, William Koltun, Kathleen Beusterien, et al.
Journal of Managed Care & Specialty Pharmacy|February 26, 2014
Barriers to mesalamine adherence in patients with inflammatory bowel disease: a qualitative analysisJennifer Devlen, Kathleen Beusterien, Linnette Yen, et al.
Vaccine|September 1, 2024
Preferences for a Clostridioides difficile vaccine among adults in the United StatesJeffrey Vietri, Martine C Maculaitis, Joseph C Cappelleri, et al.
Current Medical Research and Opinion|June 15, 2021
Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experimentTom Tencer, Oliver Will, Jinender Kumar, et al.
Patient Preference and Adherence|March 29, 2021
Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice ExperimentKathleen Beusterien, Martine C Maculaitis, Bernadette Hallissey, et al.
Patient Preference and Adherence|July 16, 2021
Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice ExperimentJinender Kumar, M Janelle Cambron-Mellott, Tom Tencer, et al.
Patient Preference and Adherence|July 31, 2024
Patient Preferences Influencing Treatment Decision-Making in Early-Stage Breast Cancer in Germany, Italy, and JapanEmuella Flood, Susan McCutcheon, Kathleen Beusterien, et al.
Neurourology and Urodynamics|September 16, 2015
Use of best-worst scaling to assess patient perceptions of treatments for refractory overactive bladderKathleen Beusterien, Michael J Kennelly, John F P Bridges, et al.
Pageof 6